Latest Breaking News On - Inding that the production cost was 10 times lower than of commercial cart cell products this has led to initiation clinical research using nonviral cells for treatment lymphoma patients in thailand prof yoshiyuki takahashi - Page 1 : comparemela.com
Chulalongkorn University, Thailand, and Nagoya University, Japan, in their collaboration to develop an immunotherapy method for curing cancer, reported on the progress of CAR T-cell immunotherapy innovation for treating cancer in leukemia and B-cell lymphoma patients, which can increase survival rates and reduce cancer recurrence. BANGKOK, April 6, 2023 /PRNewswire/ Chulalongkorn University and the Faculty of Medicine, Chulalongkorn University, organized the17thChula the Impact on "CAR T-Cell Cancer Therapy Innovation: New Hope for Thai Cancer Patients"on Tuesday, March 28, 2023, at Saranitet Conference Room, Chulalongkorn Auditorium. The talk presented the progress of CAR T-cell immunotherapy innovation for treating cancer in leukemia and B-cell lymphoma patients. This research project is a collaboration between the Cancer Immunotherapy Excellence Center, Faculty of Medicine, Chulalongkorn University, and King Chulalongkorn Memorial Hospital, Thailand, and Tokai National Hi